Song Y - Search Results

1

Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries.

Tao Y, Hao X, Jing L, Sun L, Cherukupalli S, Liu S, Wu G, Xu S, Zhang X, Shi X, Song Y, Liu X, Zhan P. Tao Y, et al. Among authors: song y. Bioorg Chem. 2021 Oct;115:105254. doi: 10.1016/j.bioorg.2021.105254. Epub 2021 Aug 9. Bioorg Chem. 2021. PMID: 34426152

2

Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents.

Cheng XC, Liu XY, Xu WF, Guo XL, Zhang N, Song YN. Cheng XC, et al. Bioorg Med Chem. 2009 Apr 15;17(8):3018-24. doi: 10.1016/j.bmc.2009.03.012. Epub 2009 Mar 13. Bioorg Med Chem. 2009. PMID: 19329327

3

Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.

Song YN, Guo XL, Zheng BB, Liu XY, Dong X, Yu LG, Cheng YN. Song YN, et al. Toxicol In Vitro. 2011 Jun;25(4):937-43. doi: 10.1016/j.tiv.2011.03.002. Epub 2011 Mar 21. Toxicol In Vitro. 2011. PMID: 21402141

4

Ligustrazine derivatives. Part 4: design, synthesis, and biological evaluation of novel ligustrazine-based stilbene derivatives as potential cardiovascular agents.

Deng L, Guo X, Zhai L, Song Y, Chen H, Zhan P, Wu J, Liu X. Deng L, et al. Among authors: song y. Chem Biol Drug Des. 2012 May;79(5):731-9. doi: 10.1111/j.1747-0285.2012.01332.x. Epub 2012 Feb 15. Chem Biol Drug Des. 2012. PMID: 22251434

5

Multivalent agents: a novel concept and preliminary practice in Anti-HIV drug discovery.

Song Y, Zhan P, Li X, Rai D, De Clercq E, Liu X. Song Y, et al. Curr Med Chem. 2013 Feb 1;20(6):815-32. Curr Med Chem. 2013. PMID: 23116144 Review.

6

Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistry.

Song Y, Zhan P, Zhang Q, Liu X. Song Y, et al. Curr Pharm Des. 2013;19(8):1528-48. Curr Pharm Des. 2013. PMID: 23131184 Review.

7

Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activities.

Song Y, Zhan P, Liu X. Song Y, et al. Curr Pharm Des. 2013;19(40):7141-54. doi: 10.2174/13816128113199990505. Curr Pharm Des. 2013. PMID: 23859548 Review.

8

Recent advances in the discovery and development of novel HIV-1 NNRTI platforms (Part II): 2009-2013 update.

Song Y, Fang Z, Zhan P, Liu X. Song Y, et al. Curr Med Chem. 2014;21(3):329-55. doi: 10.2174/09298673113206660298. Curr Med Chem. 2014. PMID: 24164196 Review.

9

"Old friends in new guise": exploiting privileged structures for scaffold re-evolution/refining.

Song Y, Chen W, Kang D, Zhang Q, Zhan P, Liu X. Song Y, et al. Comb Chem High Throughput Screen. 2014;17(6):536-53. doi: 10.2174/1386207317666140122101631. Comb Chem High Throughput Screen. 2014. PMID: 24446784 Review.

10

"Old Dogs with New Tricks": exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets.

Kang D, Song Y, Chen W, Zhan P, Liu X. Kang D, et al. Among authors: song y. Mol Biosyst. 2014 Aug;10(8):1998-2022. doi: 10.1039/c4mb00147h. Mol Biosyst. 2014. PMID: 24841339 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,283 results

Search Page

Filters